hi

Prenatal and New-born Genetic Testing Market Trends 2022 : Analysis of Key Players, Opportunities, consumption by Regional data, Size and Share, Growth by New Techniques and Forecast to 2031

Kenneth Research has recently added a report titled Prenatal and New-born Genetic Testing Market in its storehouse of market research reports. The report provides a detailed insight into the market scenario on the basis of the market size and volume for the forecast period, i.e., 2022-2031.

U S Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analysis and U.S. Census Bureau mention the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) average exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilst imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Prenatal and New-born Genetic Testing Market products.

Request For The Sample Report Here: https://www.kennethresearch.com/sample-request-10321892

Moreover, increasing expenditure on healthcare, backed by the need amongst individuals for quality healthcare services, is also anticipated to contribute to the market growth. According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018.

Global Prenatal and New-born Genetic Testing Market is valued approximately USD 13.98 Billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11.9% over the forecast period 2019-2026. Prenatal and New-Born testing is an advanced technology used for genetic screening in the healthcare industry to identify the genetic or other birth defects in newborn baby at early stage. The test is conducted during time interval of pregnancy to determine the health of the fetus at an early stage and helps in identifying various genetic and chromosomal anomalies such as birth defects, gene mutations and cystic fibrosis etc. Therefore, such advent features of prenatal and new-born genetic testing helps parents to detect early abnormal diseases in fetus to take suitable treatment. Hence, rapid growth in birth of abnormal kids along with rising cases of new-born babies with genetic disorder is expected to drive the growth of market over the forecast years. For instance: as per the World Health Organization, over an estimate 303000 newborns die within 4 weeks of birth every year globally due to the congenital anomalies. Also, as per the Centers of Diseases Control, birth defects affect one in every 33 babies (about 3% of all babies) born in the United States each year and is a leading cause of infant deaths, accounting for 20% of all infant deaths. Thus, increase in cases of birth defects in newborn baby and remarkable application of Prenatal and New-born Genetic Testing to identify it at an early stage are the factors accelerating the growth of market over the forecast years. However, lack of advanced infrastructure and skilled labor in developing region are  the factors that hamper the growth of market.

The regional analysis of global Prenatal and New-born Genetic Testing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia Pacific is the leading/significant region across the world in terms of market share owing to the due to the rapid growth in birth of abnormal kids along with rising cases of new-born babies with genetic disorder in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as advancement in genetic screening technologies in the region would create lucrative growth prospects for the Prenatal and New-born Genetic Testing market across Asia-Pacific region.

Major market player included in this report are:
Abbott Laboratories
Agilent
AutoGenomics
Ariosa Diagnostics
Baebies
Berry Genomics Co. Ltd
BGI
Biocartis Group NV
Natera Inc.
Sequenom Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Diseases offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:
Screening
Diagnostic

By Diseases:
Downs Syndrome
Phenylketonuria
Cystic Fibrosis
Sickle cell Anaemia
Others

Download Free Sample Reports Here – : https://www.kennethresearch.com/sample-request-10321892

By End-Use:
Hospitals
Maternity and Specialty Clinics
Diagnostic centers

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026

Target Audience of the Global Prenatal and New-born Genetic Testing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Prenatal and New-born Genetic Testing Market, by Region, 2018-2026 (USD Billion)
1.2.2. Prenatal and New-born Genetic Testing Market, by Technology, 2018-2026 (USD Billion)
1.2.3. Prenatal and New-born Genetic Testing Market, by Disease, 2018-2026 (USD Billion)
1.2.4. Prenatal and New-born Genetic Testing Market, by End-Use, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Prenatal and New-born Genetic Testing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Prenatal and New-born Genetic Testing Market Dynamics
3.1. Prenatal and New-born Genetic Testing Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Prenatal and New-born Genetic Testing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Prenatal and New-born Genetic Testing Market, by Technology
5.1. Market Snapshot
5.2. Global Prenatal and New-born Genetic Testing Market by Technology, Performance – Potential Analysis
5.3. Global Prenatal and New-born Genetic Testing Market Estimates & Forecasts by Technology 2016-2026 (USD Billion)
5.4. Prenatal and New-born Genetic Testing Market, Sub Segment Analysis
5.4.1. Screening
5.4.2. Diagnostic
Chapter 6. Global Prenatal and New-born Genetic Testing Market, by Disease
6.1. Market Snapshot
6.2. Global Prenatal and New-born Genetic Testing Market by Disease, Performance – Potential Analysis
6.3. Global Prenatal and New-born Genetic Testing Market Estimates & Forecasts by Disease 2016-2026 (USD Billion)
6.4. Prenatal and New-born Genetic Testing Market, Sub Segment Analysis
6.4.1. Downs Syndrome
6.4.2. Phenylketonuria
6.4.3. Cystic Fibrosis
6.4.4. Sickle cell Anaemia

Enquire before purchasing this report – >>  https://www.kennethresearch.com/sample-request-10321892

About Kenneth Research:

Kenneth Research provides scheduled syndicated reports that help industry professionals and organizations decipher market trends to take significant decisions and plan strategies. We cater to a wide range of industries including healthcare & pharmaceuticals, ICT & telecom, automotive & transportation, energy & power, chemicals, FMCG & food, aerospace & defence, among others. Our research team ensures to track and analyze the industry on a regular basis to offer strategic business consultancy services on a global level. We, at Kenneth Research, are adept at capturing descriptive insights on crucial topics to help our clients make their informed decisions.

Contact Us
Kenneth Research
Email: Sales@kennethresearch.com
Phone: +1 313 462 0911

Leave a Reply